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Editorial
There is consensus among many professionals and researchers from a wide range 
of fi elds that next year is going to be a diffi cult one for those who work in research in this 
country. It is very likely that the current fi nancial situation in Brazil will be refl ected in a 
reduced level of investment in scientifi c output by research funding agencies. It will be no 
surprise if, in 2016, there is a drop in the number of undergraduate research scholarships, 
of bursaries for domestic masters, doctoral and post-doctoral research positions and of 
grants for doctorates including foreign sandwich placements and for postdoctoral research 
posts abroad. Brazilian scientists will more than ever need to be astute and creative, 
applying their intelligence to sustaining the level of knowledge creation for which our 
country has won recognition within the wider scientifi c community. This is going to be 
a major challenge.
Notwithstanding, researchers, particularly those with less experience, must guard 
against the possibility of being held hostage to business interests. What does it mean to 
be held hostage? To be held hostage is to accept fi nancial support, in the form of fees, 
the material needed to conduct research and bonuses for production that is concluded to 
the benefi t of a brand name. In its worst form it means failing to publish results that are 
inconvenient for a manufacturer. Such approaches can be seductive in view of the scarcity 
of resources for maintenance of equipment and the lack of new investment in research. 
It must be understood that commercial products will still need to be studied before 
they can be used on human beings, but impartially and with recognition from the large 
manufacturers that we are conducting our research with integrity. Moreover, it is also 
important that young researchers are fully aware that the principles of good knowledge 
production cannot be founded on commercial brands, but are built upon good study designs 
and recognition of the value of clinical trials and epidemiological studies.
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